159 related articles for article (PubMed ID: 1790357)
1. Complement.
Davies KA
Baillieres Clin Haematol; 1991 Dec; 4(4):927-55. PubMed ID: 1790357
[TBL] [Abstract][Full Text] [Related]
2. The molecular genetics of components of the complement system.
Campbell RD
Baillieres Clin Rheumatol; 1988 Dec; 2(3):547-75. PubMed ID: 3067864
[TBL] [Abstract][Full Text] [Related]
3. The complement components of the major histocompatibility locus.
Porter RR
CRC Crit Rev Biochem; 1984; 16(1):1-19. PubMed ID: 6232112
[TBL] [Abstract][Full Text] [Related]
4. Complement sensitivity of erythrocytes in a patient with inherited complete deficiency of CD59 or with the Inab phenotype.
Shichishima T; Saitoh Y; Terasawa T; Noji H; Kai T; Maruyama Y
Br J Haematol; 1999 Feb; 104(2):303-6. PubMed ID: 10050712
[TBL] [Abstract][Full Text] [Related]
5. Complement components and receptors: deficiencies and disease associations.
Bartholomew WR; Shanahan TC
Immunol Ser; 1990; 52():33-51. PubMed ID: 2091785
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the effects of activation of the alternative pathway of complement on erythrocytes with an isolated deficiency of decay accelerating factor.
Holguin MH; Martin CB; Bernshaw NJ; Parker CJ
J Immunol; 1992 Jan; 148(2):498-502. PubMed ID: 1370313
[TBL] [Abstract][Full Text] [Related]
7. Enhanced reactive lysis of paroxysmal nocturnal hemoglobinuria erythrocytes by C5b-9 does not involve increased C7 binding or cell-bound C3b.
Rosenfeld SI; Jenkins DE; Leddy JP
J Immunol; 1985 Jan; 134(1):506-11. PubMed ID: 3964820
[TBL] [Abstract][Full Text] [Related]
8. Studies on the sensitivity to complement-mediated lysis of erythrocytes (Inab phenotype) with a deficiency of DAF (decay accelerating factor).
Merry AH; Rawlinson VI; Uchikawa M; Daha MR; Sim RB
Br J Haematol; 1989 Oct; 73(2):248-53. PubMed ID: 2479410
[TBL] [Abstract][Full Text] [Related]
9. The control of homologous lysis.
Lachmann PJ
Immunol Today; 1991 Sep; 12(9):312-5. PubMed ID: 1721817
[TBL] [Abstract][Full Text] [Related]
10. Mouse complement regulatory protein Crry/p65 uses the specific mechanisms of both human decay-accelerating factor and membrane cofactor protein.
Kim YU; Kinoshita T; Molina H; Hourcade D; Seya T; Wagner LM; Holers VM
J Exp Med; 1995 Jan; 181(1):151-9. PubMed ID: 7528766
[TBL] [Abstract][Full Text] [Related]
11. Complement regulatory proteins and autoimmunity.
Song WC
Autoimmunity; 2006 Aug; 39(5):403-10. PubMed ID: 16923540
[TBL] [Abstract][Full Text] [Related]
12. Complement-regulatory protein expression and activation of complement cascade on erythrocytes from patients with rheumatoid arthritis (RA).
Arora M; Kumar A; Das SN; Srivastava LM
Clin Exp Immunol; 1998 Jan; 111(1):102-6. PubMed ID: 9472668
[TBL] [Abstract][Full Text] [Related]
13. Implication of membrane factors other than DAF and CD59 in complement-mediated lysis of paroxysmal nocturnal hemoglobinuria erythrocytes.
Hatanaka M; Inai S; Matsumoto M; Miyagawa S; Masaoka T; Kanamaru A; Kawakita M; Yonemura Y; Sugita Y; Seya T
Clin Immunol Immunopathol; 1993 Oct; 69(1):52-9. PubMed ID: 7691453
[TBL] [Abstract][Full Text] [Related]
14. CRISPR/Cas9 generated human CD46, CD55 and CD59 knockout cell lines as a tool for complement research.
Thielen AJF; van Baarsen IM; Jongsma ML; Zeerleder S; Spaapen RM; Wouters D
J Immunol Methods; 2018 May; 456():15-22. PubMed ID: 29447841
[TBL] [Abstract][Full Text] [Related]
15. The complement components coded in the major histocompatibility complexes and their biological activities.
Porter RR
Immunol Rev; 1985 Oct; 87():7-17. PubMed ID: 3902625
[TBL] [Abstract][Full Text] [Related]
16. The erythrocytes in paroxysmal nocturnal haemoglobinuria of intermediate sensitivity to complement lysis.
Rosse WF; Hoffman S; Campbell M; Borowitz M; Moore JO; Parker CJ
Br J Haematol; 1991 Sep; 79(1):99-107. PubMed ID: 1716964
[TBL] [Abstract][Full Text] [Related]
17. Amelioration of lytic abnormalities of paroxysmal nocturnal hemoglobinuria with decay-accelerating factor.
Medof ME; Kinoshita T; Silber R; Nussenzweig V
Proc Natl Acad Sci U S A; 1985 May; 82(9):2980-4. PubMed ID: 2581259
[TBL] [Abstract][Full Text] [Related]
18. Complement genetics, deficiencies, and disease associations.
Mayilyan KR
Protein Cell; 2012 Jul; 3(7):487-96. PubMed ID: 22773339
[TBL] [Abstract][Full Text] [Related]
19. The genetics of the complement system.
Lachmann PJ; Hobart MJ
Ciba Found Symp; 1979 Jun 27-29; (66):231-50. PubMed ID: 258168
[TBL] [Abstract][Full Text] [Related]
20. Relationship between decay accelerating factor deficiency, diminished acetylcholinesterase activity, and defective terminal complement pathway restriction in paroxysmal nocturnal hemoglobinuria erythrocytes.
Medof ME; Gottlieb A; Kinoshita T; Hall S; Silber R; Nussenzweig V; Rosse WF
J Clin Invest; 1987 Jul; 80(1):165-74. PubMed ID: 2439544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
